Business
BioSpectrum Asia
Hyphens Pharma introduces acne treatment 'Winlevi' in Singapore and Malaysia
Hyphens Pharma, a subsidiary of Hyphens Pharma International Limited, Singapore's leading specialty pharmaceutical and consumer healthcare group, has announced the launch of Winlevi (clascoterone) cream 1 per cent in Singapore and Malaysia, marking its first entry into Southeast Asia.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Biotech’s Resurgence: Innovation Amid Market Disruption or A Generational Opportunity in Innovation
The biotechnology sector is showing signs of a resurgence.
3 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
China's Innovative Approach to Universal Health Coverage
China has successfully implemented various medical insurance reforms and development tasks under five principles including promoting equity and accessibility, the rule of law, technological empowerment, coordinated development and safeguarding the security of the fund during the first four years of the 14th Five-Year Plan (the 2021-2025 period).
2 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
M42 and GE HealthCare join forces to advance AI-enabled solutions in UAE
M42, a global health leader powered by technology, artificial intelligence (AI) and genomics, will collaborate with GE HealthCare, a global innovator in medical technology, pharmaceutical diagnostics and integrated, cloud-first AI-enabled digital solutions, to enhance diagnostic precision and deliver more personalised patient outcomes, marking a significant step forward in the future of smart AI healthcare in the UAE.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Singapore pledges contribution of $1 M to Gavi for better access to vaccines
The Singapore government has pledged a contribution of $1 million to Gavi, the Vaccine Alliance.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
"HSA is adopting a forward-looking 5P Strategy to tackle challenges"
Adjunct Professor (Dr) Raymond Chua, who stepped into his role as CEO of Singapore's Health Sciences Authority (HSA) in December 2024, outlines the agency's current priorities in positioning Singapore as a regional hub for biotech and medtech innovation.
6 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Japan engineers functional liver organoids with organspecific vasculature
Liver organoids with proper blood vessel networks have been successfully produced, as reported by researchers from Institute of Science Tokyo, Japan and Cincinnati Children's Hospital Medical Center in the US.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Singapore pilots innovative approach to diabetic foot care through 3D-printed custom insoles
Sengkang General Hospital (SKH) has piloted an innovative approach to diabetic foot care through in-house production of 3D-printed custom insoles in a cross-institution collaboration with Singapore General Hospital's (SGH) 3D printing centre.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Korea supports international patients through medical sharing programme
The Korea International Medical Association, represented by Chairman Young Tae Kim, has signed a Memorandum of Understanding, with the Korea Health Industry Development Institute, led by President Soon Do Cha, and GS Retail, represented by CEO Seo Hong Heo.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
DeepTek AI solution gains WHO recommendation in global fight against TB
Indian startup DeepTek, a leading medical imaging AI company, has received a significant recommendation from the World Health Organization (WHO) for its Chest X-ray AI solution for TB screening.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Novo Nordisk invests RMB 800 M to expand manufacturing plant in China
Novo Nordisk has signed a Memorandum of Understanding (MoU) with TEDA Administrative Commission, agreeing to invest approximately RMB 800 million in the expansion of quality testing laboratories at its Tianjin manufacturing plant.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Australia develops new ultrasound imaging device to map drug delivery into brain
A new device combining ultrasound and advanced imaging to provide crucial information for the safe delivery of drugs into the brain has been developed by University of Queensland researchers in Australia.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
“UK-India Free Trade Agreement helps deepen Genomics Collaboration”
Oxford Nanopore Technologies, a global company with its headquarters in the United Kingdom, has signed Letters of Intent with India's Centre for DNA Fingerprinting and Diagnostics (CDFD), and the National Institute of Biomedical Genomics (NIBMG), to develop two new genomic Centres of Excellence Institutes.
5 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
US expands access to lifesaving gene therapies
The Centers for Medicare & Medicaid Services (CMS) in the US has announced that 33 states, plus the District of Columbia and Puerto Rico, will participate in the Cell and Gene Therapy (CGT) Access Model, a bold new approach to delivering cutting-edge treatments for people on Medicaid living with sickle cell disease.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Illimis Therapeutics raises $42 M to accelerate CNS and immune disease drug development
South Korea-based startup Illimis Therapeutics has announced the closing of 58 billion KRW ($42 million) Series B financing to accelerate CNS and immune disease drug development via GAIA platform.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Merck unveils AAW workstation to advance lab automation
Merck, a leading science and technology company, has launched the Automated Assay Workstation (AAW), a solution powered by Opentrons, a leader in lab automation and accessible robotics.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Researchers in India design simple sensor for liver cancer detection
Researchers at the Indian Institute of Science (IISc), Bengaluru have developed a unique luminescent probe that uses terbium, a rare earth metal, to sense the presence of an enzyme called ẞ-glucuronidase, which can potentially aid in the detection of liver cancer.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
WHO launches bold push to raise health taxes and save millions of lives
The World Health Organization (WHO) has launched a major new initiative urging countries to raise real prices on tobacco, alcohol, and sugary drinks by at least 50 per cent by 2035 through health taxes in a move designed to curb chronic diseases and generate critical public revenue.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Australia injects nearly A$100 M in funding for emerging biomedical & medical technology solutions
The Albanese Government has awarded nearly A$100 million in funding to three organisations for emerging Australian biomedical and medical technology innovations.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Africa to decentralise diagnostics and accelerate outbreak response
In a major step toward faster and more localised outbreak response, Africa Centres for Disease Control and Prevention (CDC) convened public health leaders from ten African countries in Yaoundé to co-develop a continental framework for decentralising laboratory services.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Korean study proposes toxicity-based exposure limits for indoor airborne fungi
Airborne microorganisms, including fungi and bacteria, are major contributors to indoor air pollution, with growing links to respiratory diseases.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
"ASEAN has become an important fulcrum in the global pharmaceutical production supply chain"
Asia-based BioDlink, a full-service Contract Development and Manufacturing Organisation (CDMO) specialising in biologics and antibody-drug conjugates (ADCs), has built a strong track record over the past decade, offering integrated solutions from early-stage R&D to commercial manufacturing.
4 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
India approves Research Development and Innovation scheme with corpus of Rs 1 lakh cr
In a transformative step to bolster India's research and innovation ecosystem, the Union Cabinet, chaired by Prime Minister Narendra Modi, has approved the Research Development and Innovation (RDI) Scheme with a corpus of Rs one lakh crore.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
New Zealand enables GPs and nurse practitioners to start ADHD treatment from 2026
From February 2026, General practitioners (GPS) and nurse practitioners will be able to start medical treatment for adults with Attention Deficit Hyperactivity Disorder (ADHD), following decisions by New Zealand Medicines and Medical Devices Safety Authority and Pharmaceutical Management Agency.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Indonesia's Health Ministry inks MoU with Philips to strengthen long-term health system resilience
Royal Philips, a global leader in health technology, and Indonesia's Ministry of Health have signed Memorandum of Understanding (MoU) to strengthen the transformation of Indonesia's healthcare system through clinical capacity development, digital health innovation, and the development of training centre and service hub.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Martin Fischer steps in as President and CEO of Zeiss Greater China
Zeiss Group, an expert in Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets, has announced that Martin Fischer will officially take on the role of President and CEO of Zeiss Greater China, effective from October 1, 2025, reporting directly to Andreas Pecher, President and CEO of the Zeiss Group.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Korea-Israel partnership to commercialise injectable treatment for focal fat reduction
365mc, South Korea's leading medical institution specialising in fat reduction treatments, and Israel-based Raziel Therapeutics, a global clinical-stage biopharmaceutical company, have announced a strategic collaboration to jointly advance the clinical and commercial development of RZL-012 in South Korea.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Country wise analysis of startups with funds raising
Asia-Pacific is home to 9,905 active life sciences startups, as of July 20, 2025, according to Tracxn. Of these, 4,289 have secured funding, and 1,840 have advanced to Series A or later stages.
2 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
China approves world's first dual GCG/GLP-1 receptor agonist for weight loss
Innovent Biologics, Inc. has announced that China's National Medical Products Administration (NMPA) has approved mazdutide a first-in-class dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in Chinese adults with overweight or obesity.
1 min |
BioSpectrum Asia August 2025
BioSpectrum Asia
Indian firm Biological E partners with China's Recbio to produce HPV9 vaccine
Jiangsu Recbio Technology, a leading Chinese biopharmaceutical company, has entered into a licensing cooperation agreement, and have commenced the technology transfer of their Recombinant 9-valent HPV (HPV9) vaccine, REC603, to Biological E.Limited BE, a leading Indian vaccine and pharmaceutical company.
1 min |